相关实验视频
Updated: Jan 13, 2026

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.8K
微炎症驱动的基因表达动力学在代谢障碍和癌症的发病过程中
Marian Elisa Gabrielle T Cadungog1,2, Lemmuel L Tayo3
1School of Chemical, Biological, and Materials Engineering and Sciences, Mapúa University, Manila 1002, Philippines.
Biology
|January 10, 2026
概括
微炎症通过共享的分子通路将代谢疾病和癌症联系在一起. 这项研究确定了保存的RNA处理和蛋白质稳定签名作为关键驱动因素,提供了新的治疗点.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 在瘤学瘤学.
背景情况:
- 微炎症是连接代谢疾病和癌症的关键因素.
- 这些条件背后的共同分子机制仍然不完全理解.
研究的目的:
- 在代谢疾病和癌症中识别炎症介导病理的常见分子驱动因素.
- 探索RNA处理和蛋白质稳定在这些相互关联的疾病中的作用.
主要方法:
- 从易怒肠综合征 (IBS),肥胖,2型糖尿病 (T2D),结直肠癌 (CRC),细胞癌 (RCC) 和胰腺癌 (PC) 的基因表达特征的整合.
- 权重基因共同表达网络分析 (WGCNA) 以确定保存的基因模块和枢纽基因.
- 调节性微RNA (miRNA) 和它们的网络相互作用的分析.
主要成果:
- 鉴定了三个高度保存的基因模块 (蓝色,棕色,绿色),在RNA处理,结合体组装,核糖体生物发生和蛋白质稳定中得到丰富.
- 关键的枢纽基因和调节性miRNAs形成相互连接的网络,调节转录,mRNA成熟,蛋白质合成和炎症信号.
- 炎症似乎通过RNA处理和蛋白质稳定中断的间接调节,可能受到肠道微生物群和代谢状态的影响.
结论:
- 保存的分子特征将微炎症,代谢性疾病和瘤发生联系起来.
- RNA调节,蛋白质稳定和miRNA介导的控制是潜在的诊断和治疗目标.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Regulation of Metabolism
11.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.4K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K

